Muna Bhanji

Insider Reports History

Location
C/O Cytokinetics, Incorporated, 280 East Grand Avenue, South San Francisco, CA
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for Muna Bhanji
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Muna Bhanji:

Stock Role Class Num Shares Value Price $ Report Date Ownership
VERACYTE, INC. Director Common Stock 39.3K $1.21M $30.84 Jun 18, 2025 Direct
CYTOKINETICS INC Director Common Stock 23.5K $699K $29.73 May 15, 2025 Direct
ARDELYX, INC. Director Common Stock 137K $497K $3.62 Jun 18, 2025 Direct
Intellia Therapeutics, Inc. Director Common Stock 27.2K $226K $8.32 Jun 11, 2025 Direct
CYTOKINETICS INC Director Non-Qualified Stock Option (Right to Buy) 3.64K $152K $41.69 May 15, 2024 Direct
ARDELYX, INC. Director Stock Option (Right to Buy) 54.1K $93.4K $2.32 Jun 18, 2025 Direct
Intellia Therapeutics, Inc. Director Stock Option (right to buy) 11.5K Jun 11, 2025 Direct
CYTOKINETICS INC Director Non-Qualified Stock Option (Right to Buy) 10.9K May 14, 2025 Direct

Insider Reports Filed by Muna Bhanji

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ARDX ARDELYX, INC. Jun 18, 2025 2 $0 4 Jun 23, 2025 Director
VCYT VERACYTE, INC. Jun 18, 2025 1 $0 4 Jun 23, 2025 Director
VCYT VERACYTE, INC. Jun 13, 2025 1 -$122K 4 Jun 17, 2025 Director
NTLA Intellia Therapeutics, Inc. Jun 11, 2025 2 $0 4 Jun 13, 2025 Director
CYTK CYTOKINETICS INC May 15, 2025 1 -$43.2K 4 May 15, 2025 Director
CYTK CYTOKINETICS INC May 14, 2025 2 $0 4 May 14, 2025 Director
NTLA Intellia Therapeutics, Inc. Apr 29, 2025 1 -$2.25K 4 May 1, 2025 Director
NTLA Intellia Therapeutics, Inc. Jan 29, 2025 1 -$2.64K 4 Jan 31, 2025 Director
ARDX ARDELYX, INC. Jun 14, 2024 1 $0 4 Jun 17, 2024 Director
VCYT VERACYTE, INC. Jun 13, 2024 1 $0 4 Jun 17, 2024 Director
NTLA Intellia Therapeutics, Inc. Jun 12, 2024 2 $0 4 Jun 14, 2024 Director
VCYT VERACYTE, INC. Jun 10, 2024 1 -$78.6K 4 Jun 11, 2024 Director
CYTK CYTOKINETICS INC Jun 10, 2024 1 -$104K 4 Jun 10, 2024 Director
VCYT VERACYTE, INC. May 28, 2024 1 -$32.3K 4 May 30, 2024 Director
CYTK CYTOKINETICS INC May 15, 2024 2 $0 4 May 16, 2024 Director
NTLA Intellia Therapeutics, Inc. Oct 31, 2023 1 -$6.33K 4 Nov 2, 2023 Director
NTLA Intellia Therapeutics, Inc. Jul 31, 2023 1 -$11.2K 4 Aug 2, 2023 Director
CYTK CYTOKINETICS INC Jul 7, 2023 1 -$68.2K 4 Jul 7, 2023 Director
NTLA Intellia Therapeutics, Inc. Jul 6, 2023 1 -$73.4K 4 Jul 10, 2023 Director
VCYT VERACYTE, INC. Jun 16, 2023 2 -$156K 4 Jun 21, 2023 Director
ARDX ARDELYX, INC. Jun 15, 2023 1 $0 4 Jun 16, 2023 Director
NTLA Intellia Therapeutics, Inc. Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
VCYT VERACYTE, INC. Jun 9, 2023 1 $0 4 Jun 13, 2023 Director
VCYT VERACYTE, INC. May 30, 2023 1 -$39.9K 4 Jun 1, 2023 Director
CYTK CYTOKINETICS INC May 10, 2023 2 $0 4 May 18, 2023 Director
CYTK CYTOKINETICS INC Oct 3, 2022 1 $11.2K 4 Oct 5, 2022 Director
CYTK CYTOKINETICS INC Jul 1, 2022 1 $11.2K 4 Jul 12, 2022 Director
VCYT VERACYTE, INC. Jun 16, 2022 1 $0 4 Jun 16, 2022 Director
ARDX ARDELYX, INC. Jun 15, 2022 2 $0 4 Jun 17, 2022 Director
NTLA Intellia Therapeutics, Inc. Jun 14, 2022 2 $0 4 Jun 16, 2022 Director
CYTK CYTOKINETICS INC May 10, 2022 2 $0 4 May 11, 2022 Director
NTLA Intellia Therapeutics, Inc. Apr 28, 2022 2 $0 4 May 2, 2022 Director
NTLA Intellia Therapeutics, Inc. Apr 28, 2022 0 $0 3 May 2, 2022 Director
CYTK CYTOKINETICS INC Apr 1, 2022 1 $11.2K 4 Apr 1, 2022 Director
CYTK CYTOKINETICS INC Jan 3, 2022 1 $11.2K 4 Jan 4, 2022 Director
CYTK CYTOKINETICS INC May 12, 2021 2 $0 4 May 13, 2021 Director